Atlas Trials

Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment

Clinical trial NCT03224221 · UNKNOWN

Trial details

NCT number
NCT03224221
Sponsor
The First Affiliated Hospital of Anhui Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2017-03-23
Primary completion
2019-01-23
Enrollment
189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.